Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2021-03-17 / Mol Clin Oncol 2021 May;14(5):103Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2020-10-01 / Arch Razi Inst 2020 10;75(3):367-376NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2020-09-28 / J Cell Biochem 2021 Jan;122(1):3-15Exhaustion of Protective Heat Shock Response Induces Significant Tumor Damage by Apoptosis after Modulated Electro-Hyperthermia Treatment of Triple Negative Breast Cancer Isografts in Mice
/in Breast Cancer, Hyperthermia, International Publications /von 2020-09-10 / Cancers (Basel) 2020 Sep;12(9)Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2020-08-28 / Cancer Cell Int 2020;20:420Newcastle disease virus suppress glycolysis pathway and induce breast cancer cells death
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2020-06-27 / Virusdisease 2020 Sep;31(3):341-348Combined wIRA-Hyperthermia and Hypofractionated Re-Irradiation in the Treatment of Locally Recurrent Breast Cancer: Evaluation of Therapeutic Outcome Based on a Novel Size Classification
/in Breast Cancer, Hyperthermia, International Publications /von 2020-03-06 / Cancers (Basel) 2020 Mar;12(3)Dendritic cell vaccine for the effective immunotherapy of breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2020-03-04 / Biomed. Pharmacother. 2020 Jun;126:110046Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells
/in Breast Cancer, Dendritic Cells, International Publications /von 2020-01-23 / Oncol Lett 2020 Mar;19(3):2422-2430
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de